See more : Giantec Semiconductor Corporation (688123.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Medartis Holding AG (MDRSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medartis Holding AG, a leading company in the Medical – Devices industry within the Healthcare sector.
- Sansei Co.,Ltd. (6307.T) Income Statement Analysis – Financial Results
- Chugin Financial Group,Inc. (5832.T) Income Statement Analysis – Financial Results
- Teleste Corporation (TLT1V.HE) Income Statement Analysis – Financial Results
- Innovent Biologics, Inc. (IVBXF) Income Statement Analysis – Financial Results
- Cinda Real Estate Co., Ltd. (600657.SS) Income Statement Analysis – Financial Results
Medartis Holding AG (MDRSF)
About Medartis Holding AG
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 212.01M | 182.82M | 159.88M | 127.65M | 130.14M | 121.32M | 105.04M | 92.50M | 82.30M |
| Cost of Revenue | 44.43M | 47.44M | 38.31M | 33.76M | 28.84M | 20.31M | 17.48M | 16.50M | 14.15M |
| Gross Profit | 167.57M | 135.39M | 121.57M | 93.89M | 101.30M | 101.01M | 87.57M | 76.00M | 68.15M |
| Gross Profit Ratio | 79.04% | 74.05% | 76.04% | 73.55% | 77.84% | 83.26% | 83.36% | 82.16% | 82.80% |
| Research & Development | 25.91M | 23.52M | 17.78M | 14.24M | 13.67M | 13.23M | 11.36M | 9.46M | 8.79M |
| General & Administrative | 34.48M | 29.99M | 25.96M | 21.75M | 23.46M | 21.43M | 19.86M | 20.91M | 16.74M |
| Selling & Marketing | 97.51M | 94.34M | 77.09M | 65.47M | 65.91M | 60.29M | 46.73M | 38.30M | 30.42M |
| SG&A | 131.99M | 113.74M | 92.78M | 76.55M | 80.27M | 81.73M | 66.59M | 59.21M | 47.16M |
| Other Expenses | 573.00K | 0.00 | 0.00 | 0.00 | 0.00 | -601.11K | -2.00 | 102.99K | 51.38K |
| Operating Expenses | 158.47M | 137.26M | 110.56M | 90.79M | 93.95M | 94.95M | 77.96M | 68.77M | 56.00M |
| Cost & Expenses | 202.90M | 184.69M | 148.87M | 124.55M | 122.79M | 115.27M | 95.43M | 85.27M | 70.16M |
| Interest Income | -1.03M | 249.82K | 135.31K | 365.29K | 249.89K | 155.30K | 122.91K | 42.05K | 24.35K |
| Interest Expense | 1.73M | 4.62M | 1.47M | 1.37M | 1.96M | 533.67K | 724.07K | 961.72K | 1.09M |
| Depreciation & Amortization | 13.25M | 18.11M | 16.39M | 15.89M | 12.99M | 8.35M | 7.26M | 6.74M | 6.36M |
| EBITDA | 24.69M | 16.24M | 26.10M | 13.96M | 20.34M | 11.25M | 16.95M | 12.99M | 15.11M |
| EBITDA Ratio | 11.65% | 8.88% | 17.14% | 14.88% | 15.63% | 9.28% | 15.26% | 14.05% | 18.36% |
| Operating Income | 9.10M | -1.87M | 11.01M | 3.10M | 7.35M | 6.06M | 9.61M | 7.23M | 12.15M |
| Operating Income Ratio | 4.29% | -1.02% | 6.89% | 2.43% | 5.65% | 4.99% | 9.15% | 7.82% | 14.76% |
| Total Other Income/Expenses | -7.31M | -5.22M | -2.77M | -6.40M | -4.04M | -3.69M | -1.56M | -1.94M | -4.49M |
| Income Before Tax | 1.79M | -7.09M | 8.25M | -3.30M | 3.32M | 2.37M | 8.05M | 5.29M | 7.65M |
| Income Before Tax Ratio | 0.85% | -3.88% | 5.16% | -2.58% | 2.55% | 1.95% | 7.66% | 5.72% | 9.30% |
| Income Tax Expense | 1.17M | -1.36M | 1.45M | -2.32M | 1.17M | -1.83M | 7.18M | 1.98M | 381.82K |
| Net Income | 619.00K | -5.78M | 6.84M | -943.57K | 2.15M | 4.20M | 866.52K | 3.31M | 7.27M |
| Net Income Ratio | 0.29% | -3.16% | 4.28% | -0.74% | 1.65% | 3.46% | 0.82% | 3.58% | 8.83% |
| EPS | 0.05 | -0.49 | 0.58 | -0.08 | 0.18 | 0.40 | 0.07 | 0.28 | 0.62 |
| EPS Diluted | 0.05 | -0.49 | 0.58 | -0.08 | 0.18 | 0.40 | 0.07 | 0.28 | 0.62 |
| Weighted Avg Shares Out | 12.23M | 11.83M | 11.80M | 11.77M | 11.74M | 10.63M | 11.73M | 11.74M | 11.74M |
| Weighted Avg Shares Out (Dil) | 12.23M | 11.83M | 11.80M | 11.77M | 11.74M | 10.63M | 11.74M | 11.74M | 11.74M |
Source: https://incomestatements.info
Category: Stock Reports